Evonik is investing into its US Specialty Methacrylate plant
Expanded crosslinker portfolio at Mobile site
Evonik is expanding its production capacities for methacrylate crosslinkers of the VISIOMER® brand. To this end, the Methacrylates Business Line has made an investment in the low single-digit million-euro range at the Mobile site (Alabama, USA). The start-up is scheduled for the third quarter of 2018.
“With this investment, we will further improve the global positioning of Application Monomers. It will allow us to provide customers with crosslinkers from our plants in the US, Germany, and China,” explains Hans-Peter Hauck, head of the Methacrylates Business Line in the Performance Materials Segment.
“In the future, we will be able to provide methacrylate crosslinkers for the US market out of Mobile plant,” continues Grant Lafontaine, general manager of the Application and Bulk Monomers Product Lines in the US. “We will thereby significantly improve our flexibility and responsiveness for the benefit of our customers in the US.”
The investment in Mobile will continue to develop the strengths of the methacrylates business including leading market positions, operative excellence, strong brands, leading technologies and excellent network structures. To ensure future development of these strengths, Evonik is currently looking for the best owner for its methacrylates business, which is being set up as an independent entity. The aim is to find a new owner who will invest in the long term growth of the methacrylates business ensuring it a bright and successful future.
Other news from the department business & finance
